ArticleFrontiers in oncology2022

CD49b Targeting Inhibits Tumor Growth and Boosts Anti-tumor Immunity.

Pamina Contreras-Kallens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.